Phase I Study of Recombinant Human Interleukin-2 for Pediatric Malignancies: Feasibility of Outpatient Therapy. A Pediatric Oncology Group Study

Journal article

Peer reviewed

Ray C. Pais, Aly Abdel-Mageed, Thad T. Ghim, David Ode, Eliazer Melendez, Hueng Sik Kim, Harry Findley, Abdelsalam H. Ragab and Ahmed H. H. Ragab

Journal of immunotherapy (1997), Vol.12(2), pp.138-146

01/08/1992

PMID: 1504055

Metrics

1 Record Views

Title: Phase I Study of Recombinant Human Interleukin-2 for Pediatric Malignancies: Feasibility of Outpatient Therapy. A Pediatric Oncology Group Study
Creators - without role: Ray C. Pais - Emory University
Aly Abdel-Mageed
Thad T. Ghim
David Ode
Eliazer Melendez
Hueng Sik Kim
Harry Findley
Abdelsalam H. Ragab
Ahmed H. H. Ragab - King Khalid University
Publication Details: Journal of immunotherapy (1997), Vol.12(2), pp.138-146
Identifiers: 9922513208331
Academic Unit: King Khalid University
Language: English
Resource Type: Journal article